Basic Cardiovascular Sciences 2025  /  The Age of Metabolism  /  How Do SGLT2 Inhibitors Reduce Cardiovascular Events and Heart Failure?
Logo

American Heart Association

  130
  0

Final ID:

How Do SGLT2 Inhibitors Reduce Cardiovascular Events and Heart Failure?

  • Arany, Zoltan  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Zoltan Arany: DO NOT have relevant financial relationships
Meeting Info:

Basic Cardiovascular Sciences 2025

2025

Baltimore, Maryland

Session Info:

The Age of Metabolism

Friday, 07/25/2025 , 03:15PM - 04:30PM

General Session

More abstracts on this topic:
Recent Findings and unresolved questions in understanding Mitochondrial ISR

Fang Xi

Foxm1-Mediated Mitochondrial Function in Cardiomyocytes Protects Cardiac Ischemic Injury Through Suppressing Mkrn1-Dependent LKB1 Ubiquitination

Song Shuai, Zhang Xiaokai, Sun Aijun, Ge Junbo

More abstracts from these authors:
One Carbon Metabolism Defect In Failing Hearts

Jung Jae Woo, Flam Emily, Bedi Kenneth, Jang Cholsoon, Rabinowitz Joshua, Margulies Kenneth, Arany Zoltan

Metabolomic Profile of Human End-Stage Ischemic Cardiomyopathy Reveals Few Differences from Non-Ischemic Cardiomyopathy

Tanosaki Sho, Bedi Kenneth, Margulies Kenneth, Arany Zoltan

You have to be authorized to contact abstract author. Please, Login
Not Available